NR1H4 and obesity disorder: FXR is known as a key regulator of cholesterol and lipid homeostasis, and several studies have reported the correlation between kidney dysfunction and kidney lipid accumulation in various disease models, including metabolic disease (obesity, metabolic syndrome, and diabetes mellitus), AKI, and CKD28.